Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKinsey
Boehringer Ingelheim
Mallinckrodt
Dow

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Details for Patent: 8,357,394


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,357,394 protect, and when does it expire?

Patent 8,357,394 protects MOXATAG and is included in one NDA.

This patent has eleven patent family members in six countries.

Summary for Patent: 8,357,394
Title:Compositions and methods for improved efficacy of penicillin-type antibiotics
Abstract: Disclosed are once-a-day penicillin-type antibiotic products comprising at least one modified release dosage form comprising penicillin-type antibiotics and pharmaceutically acceptable carriers, which compositions provide T>MIC.sub.90 in the serum for at least 5 hours (preferably for at least five consecutive hours), within a 24-hour dosing interval, for a given bacterial pathogen's MIC.sub.90, while providing a total dosage of the penicillin-type antibiotic for a 24-hour dosing interval.
Inventor(s): Flanner; Henry H. (Montgomery Village, MD), Guttendorf; Robert J. (Gaitherburg, MD), Clausen; Susan P. (Ijamsville, MD), Treacy; Donald (Woodbine, MD), Burnside; Beth A. (Bethesda, MD)
Assignee: Shionogi Inc. (Florham Park, NJ)
Application Number:11/636,291
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

Drugs Protected by US Patent 8,357,394

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pragma MOXATAG amoxicillin TABLET, EXTENDED RELEASE;ORAL 050813-001 Jan 23, 2008 DISCN Yes No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,357,394

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006321782 ⤷  Try it Free
Australia 2006351475 ⤷  Try it Free
Canada 2635378 ⤷  Try it Free
Canada 2635606 ⤷  Try it Free
China 101563466 ⤷  Try it Free
European Patent Office 1968586 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Baxter
McKinsey
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.